Oral vaccination of mice against rodent malaria with recombinant Lactococcus lactis expressing MSP-119

World Journal of Gastroenterology

Volumn 11, Issue 44, 2005, Pages 6975-6980

  Zhang, Zhi Hong ^a   Jiang, Pei Hong ^a   Li, Ning Jun ^a   Shi, Mi ^a   Huang, Weida ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Lactococcus lactis; Malaria; Oral delivery vaccination

Indexed keywords

MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DEATH; DEVELOPMENTAL STAGE; DRUG EFFICACY; DRUG FORMULATION; DRUG SCREENING; GENETIC ENGINEERING; GENETIC RECOMBINATION; INFECTION PREVENTION; LACTOCOCCUS LACTIS; MALARIA; MOUSE; MOUSE STRAIN; NONHUMAN; PARASITE DEVELOPMENT; PARASITEMIA; PLASMODIUM YOELII; PROTEIN EXPRESSION; PROVOCATION TEST; RODENT DISEASE; SURVIVAL; VACCINATION;

EID: 31144445836     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i44.6975     Document Type: Article

References (27)

1. Cooper JA. Merozoite surface antigen-1 of Plasmodium. Parasitol. Today 1993; 9: 50-54
2. Holder AA, Blackman MJ. What is the function of MSP-1 on the malaria merozoite. Parasitol. Today 1994; 10: 182-184
3. Holder AA, Freeman RR. Immunization against blood-stage rodent malaria using purified parasite antigens. Nature 1981; 294: 361-364
4. Siddiqui WA, Tam LQ, Kramer KJ, Hui GS, Case SE, Yamaga KM, Chang SP, Chan EB, Kan SC. Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. Proc Natl Acad Sci USA 1987; 84: 3014-3018
5. Tian JH, Kumar S, Kaslow DC, Miller LH. Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii. Infect Immun 1997; 65: 3032-3036
6. Holder AA, Sandhu JS, Hillman Y, Davey LS, Nicholls SC, Cooper H, Lockyer MJ. Processing of the precursor to the major merozoite surface antigens of Plasmodium falciparum. Parasitology 1987; 94: 199-208
7. Blackman MJ, Ling IT, Nicholls SC, Holder AA. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol Biochem Parasitol 1991; 49: 29-33
8. Blackman MJ, Heidrich HG, Donachie S, McBride JS, Holder AA. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J Exp Med 1990; 172: 379-382
9. Miller LH, Roberts T, Shahabuddin M, McCutchan TF. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol Biochem Parasitol 1993; 59: 1-14
10. Kang Y, Long CA. Sequence heterogeneity of the C-terminal, Cys-rich region of the merozoite surface protein-1 (MSP-1) in field samples of Plasmodium falciparum. Mol Biochem Parasitol 1995; 73: 103-110
11. Renia L, Ling IT, Marussig M, Miltgen F, Holder AA, Mazier D. Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge. Infect Immun 1997; 65: 4419-4423
12. Matsumoto S, Yukitake H, Kanbara H, Yamada T. Recombinant Mycobacterium bovis bacillus Calmette-Guerin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies. J Exp Med 1998; 188: 845-854
13. Tian JH, Kumar S, Kaslow DC, Miller LH. Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii. Infect Immun 1997; 65: 3032-3036
14. Perera KL, Handunnetti SM, Holm I, Longacre S, Mendis K. Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria. Infect Immun 1998; 66: 1500-1506
15. Calvo PA, Daly TM, Long CA. Plasmodium yoelii: the role of the individual epidermal growth factor-like domains of the merozoite surface protein-1 in protection from malaria. Exp. Parasitol 1996; 82: 54-64
16. Daly TM, Long CA. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. J Immunol 1995; 155: 236-243
17. Ling IT, Ogun SA, Holder AA. The combined epidermal growth factor-like modules of Plasmodium yoelii Merozoite Surface Protein-1 are required for a protective immune response to the parasite. Parasite Immunol 1995; 17: 425-433
18. Hackett J. Use of Salmonella for heterologous gene expression and vaccine delivery systems. Curr Opin Biotechnol 1993; 4: 611-615
19. Holmgren J, Czerkinsky C. Cholera as a model for research on mucosal immunity and development of oral vaccines. Curr Opin Immunol 1992; 4: 387-391
20. Mercenier A, Muller-Alouf H, Grangette C. Lactic acid bacteria as live vaccines. Curr Issues Mol Biol 2000; 2: 17-25
21. Robinson K, Chamberlain LM, Schofield KM, Wells JM, Le Page RW. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat Biotechnol 1997; 15: 653-657
22. de Vos WM. Gene expression systems for lactic acid bacteria. Curr Opin Microbiol 1999; 2: 289-295
23. Lee MH, Roussel Y, Wilks M, Tabaqchali S. Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice. Vaccine 2001; 19: 3927-3935
24. O'Sullivan DJ, Klaenhammer TR. High- and low-copy-number Lactococcus shuttle cloning vectors with features for clone screening. Gene 1993; 137: 227-231
25. Posno M, Leer RJ, Luijk N, Giezen MJF, Heuvelmans PTH. M, Lokman BC, Pouwels PH. Incompatibility of Lactobacillus vectors with replicons derived from small cryptic lactobacillus plasmids and segregational instability of the introduced vectors. Applied and Environmental Microbiology 1991; 57: 1822-1828
26. Harlow E, Lane D. Antibodies: a laboratory manual. Cold Spring Harbor: Cold Spring Harbor Lab press 198827. Savijoki K, Kahala M, Palva A. High level heterologous protein production in Lactococcus and Lactobacillus using a new secretion system based on the Lactobacillus brevis S-layer signals. Gene 1997; 186: 255-262
27. Tian JH, Miller LH, Kaslow DC, Ahlers J, Good MF, Alling DW, Berzofsky JA, Kumar S. Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine. J Immunol 1996; 157: 1176-1183